Comparative Clinical Study of 2 Drug Vatnashini Vati and Rasnadi Guggul in the treatment of Gridhrasi W.S.R. to Sciatica.

An Open Randomized Comparative Clinical Study of Vatanadhini Vati (Rasachintamani) With Rasnadi Guggul (Yogaratnakar) in the Management of Gridhrasi W.S.R. to Sciatica. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067332

Enrollment

Registered

2024-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Patients having pratyatmalakshana of Gridhrasi Patients having positive SLR test Tenderness along the course of sciatic nerve

Exclusion criteria

Exclusion criteria: 1. In secondary Complication- Tuberculosis of the vertebral column. 2. Spinal deformity, spinal tumors, severe traumatic injury, Carcinoma of spine 3. Patient of Gridhrasi involving any structural deformities and needs surgical care/intervention will excluded. 4. Pregnant women and lactating mothers. 5. Uncontrolled diabetes mellitus, cardiovascular disease.

Design outcomes

Primary

Measure	Time frame
Straight leg raise test (in degree) Timepoint: Baseline, 7th, 14th, 21st and 28th day	—

Secondary

Measure	Time frame
To assess the following symptoms along the sciatic nerve route in Mild Moderate & Severe scale Pain Pricking sensation Stiffness Twitching Timepoint: Baseline, 7th, 14th, 21st & 28th day.	—

Countries

India

Contacts

Public ContactUmesh Baburao Rathod

APMS Ayurved Mahavidyalay,Mumbai

vidya.rao163@gmail.com9820725950

Outcome results